The Comparison of Comprehensive Multi-disciplinary Program and Conventional Care Program on Fragility Fracture Elderly

Overview

Fragility fractures are one of the commonest injuries among elderly people in Hong Kong and account for 12% of the disease burden in elderly aged 65 or above. A good management healthcare program and training helps elderly to restore full functional level and prevent re-fracture in the following 2 years after primary fracture, but Hong Kong lacks of such program. Some reports from other countries pointed out a well-organized multi-disciplinary management programs are cost-effective to identify and treat osteoporosis, reduce the fracture rate, improve quality of life and raise awareness of fragility fracture. This study aims to compare the cost-effectiveness of multi-disciplinary management program with conventional care controls. The clinical effectiveness outcomes (re-fracture rate, fall rate, mortality, mobility, quality of life and specialist follow-up time) of the fragility hip fracture patients in New Territories East receiving the proposed management program will be compared with those from Kowloon Central with usual care as controls. The findings will provide useful data for the policy maker to evaluate the current clinical service for fragility fracture patients and consider the implementation of new multi-disciplinary management program into our healthcare system.

Full Title of Study: “Medico-social Impact of a Comprehensive Multi-disciplinary Program for the Care of Fragility Fracture of the Elderly -Implications for Healthcare Policy in Hong Kong”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: Single (Participant)
  • Study Primary Completion Date: December 2012

Interventions

  • Other: Multi-disciplinary management program
    • conventional healthcare program for fragility fracture patients plus vibration treatment, exercise class and educational talk

Arms, Groups and Cohorts

  • No Intervention: Conventional care program
  • Experimental: Multi-disciplinary management program

Clinical Trial Outcome Measures

Primary Measures

  • Cost effectiveness of the multi-disciplinary management program and conventional care program
    • Time Frame: 1 year
    • The expected costs of fragility fracture treatment and re-fracture at the hip are calculated from the prospective of hospital and community center cost, with a time frame of one year.

Secondary Measures

  • Mobility
    • Time Frame: 1 year
    • The patients will be asked to perform mobility assessments according to our established protocol, including timed-up-to-go, mobility score, Berg balance scale and fall risk screening. The result of the above assessments will be reported as a scoring to show the level of fall risk of the patient.

Participating in This Clinical Trial

Inclusion Criteria

  • Fragility hip fracture patients within age 65-90 Exclusion Criteria:

  • Taking medication affecting bone metabolism or intensive exercise training; – Those living in old age homes or anyone who is not able to comply with our program

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Chinese University of Hong Kong
  • Collaborator
    • Queen Elizabeth Hospital, Hong Kong
  • Provider of Information About this Clinical Study
    • Principal Investigator: Kwok-Sui Leung, Chair Professor – Chinese University of Hong Kong
  • Overall Official(s)
    • Kwok-Sui Leung, MD, Principal Investigator, Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.